Sandra Zinkel Archives
Cell death pathway implicated in bone marrow failure
Jan. 31, 2019—Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.
Novel genetic study sheds new light on risk of heart attack
Oct. 11, 2018—Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.
VU investigators land ‘bridge grants’ from hematology society
Aug. 22, 2013—Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts.
Probing roles of a cell death protein
Jul. 17, 2013—Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations.
Bid protein guards blood cells against stress
Oct. 25, 2012—A protein normally known to promote cell death found to encourage survival of blood forming cells.